Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings
CNBC Earnings
Barrons Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

Stocktwits
MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-

Igm Biosciences, Inc. Common Stock | IGMS

Daily Technical Analysis of Igm Biosciences, Inc. Common Stock

Igm Biosciences had a rough day and is now down -6.25%. Investors weren't too impressed with the future outlook for the asset which caused some selling on weak demand.

Igm Biosciences doesn't seem to be at a very clear reversal point in either direction. Igm Biosciences has been drifting up over the last few months, we'll see if it has the energy to keep moving in the right direction. IGMS might find some support at the 15.25 level, buyers might push the price back up from here. But it's not very clear what will happen.


Last analyzed on 2024-03-17

Analyst Ratings for Igm Biosciences By Price Target And Rating

The analysts feel fairly neutral on the prospects for IGM Biosciences but a little more positive than negative. The current Analysts Sentiment Score is 11.43. Most companies range between (-200 to 200).

Here's a break down of the latest rating changes. Royal Bank of Canada announced an upgrade on 2024-02-09 from Sector Perform to Outperform and moved up their price target to $21.00 which is a 133.33% increase. Bank of America released a downgrade on 2023-12-15 from Buy to Neutral and added a price target of $8.00. On 2023-12-07 HC Wainwright downgraded IGM Biosciences from Buy to Neutral and decided to decrease their price target by -36.36% down to $7.00. Morgan Stanley announced a lowering of their price target to $8.00 from $15.00 on 2023-11-15. On 2023-11-14 Stifel Nicolaus lowered their price target by -3.85% to $25.00. On 2023-11-14 there was confirmation of the previous rating by Wedbush which was Outperform and they lowered their price target by -15.79% to $16.00 from a previous target of $19.00. On 2023-09-06 there was confirmation of the previous rating by Truist Financial which was Buy and added a price target of $25.00. Robert W. Baird provided a price target decease of -45.16% to $17.00 from $31.00 on 2023-08-07. Guggenheim dropped their price target by -34.21% to $25.00 on 2023-08-07. Needham & Company LLC announced that they are reiterating a rating of Buy on 2023-08-07.

Company Ratings Score ?
Composite analyst sentiment score
Positive Ratings Negative Ratings Boost Price Target Lower Price Target
IGMS11.4368.72-50.8552-47

Earnings Per Share (EPS) Estimates By Year and Quarter

(updated 2024-04-17)
Company YOY Growth Score (typical -20 to +20) Revision Directions (-6 to +6)
IGMS0.000.00

Short interest for IGM Biosciences

We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.

Company Short Score (typical 1-15) ?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
Short Interest Days to Cover Rate of Change Shares Short
IGMS22.02%26.314.312.6064850000

Social Sentiment for IGM Biosciences

Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.

Ticker Social Sentiment(1-10)
IGMS

Companies with the highest correlation to IGM Biosciences

Company Score 1 Day% 5 Day 1 Month 3 Month 6 Month 1 Year RSI 3mo S-momo ? 6mo S-momo 1yr S-momo Resistance ? Support Demark Sell ? Demark Buy Short Interest Score
DNLI | Denali Therapeutics Inc. 0.79-0.06-7.79-19.53-5.22-12.72-36.3544-10.54-23.64-26.73-17158.84-1907.180011.2371

Top 3 correlating companies

See full charts for all peers

Sentiment Score

Last updated 2021-11-10 14:47:49

How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.

Earnings Estimates
Analyst Rating
Price Targets
Short Interest
Financials
Options Sentiment
Institutional Ownership
Social Sentiment
Fidelity Summary
Overall Summary Notes
Calculated Sentiment Sum

Score Sum
(1-45)

/

Average
(1-5)

+

Pattern Rank
(1-5)

=

Total Score
(1-10)

Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-